SOLTI-1507: A phase Ib study of ipatasertib and anti-HER2 therapy in HER2-positive advanced breast cancer with PIK3CA mutation (IPATHER)
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Oliveira, M.
Villagrasa, P.
Ciruelos, E. M.
Gavila, J.
Cortegoso, A.
Henao, F.
Vega, E.
Salvador, J.
Quiroga, V.
Estevez, L. G.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
